Skip to main content
. Author manuscript; available in PMC: 2011 Mar 15.
Published in final edited form as: Contemp Clin Trials. 2009 Jul 25;30(6):531–539. doi: 10.1016/j.cct.2009.07.001

Table 2.

Schedule of Measurements


Screen Baseline Operative 3 months 12 months

UDI
PGI-I
PGI-S
Stress Test
UDS
Additional Treatment
SF-12
IIQ-7
ISI
MESA
Voiding Function
Patient Satisfaction
Patient Preparedness
Adverse Events
Urine Dipstick
Costs & Utilities
Sociodemographic
Comorbidities
H&P
PVR
Medication Audit
Prolapse Assessment
Urethral Mobility
Operative Measures
MD Dx & Tx Info.

UDI-Urogenital Distress Inventory[10]; PGI-I- Patient Global Impression of Improvement[1113]; PGI-S-Patient Global Impression of Severity [1113]; UDS-Urodynamics; SF-12-Short Form-12; IIQ-7-Incontinence Impact Questionnaire-7; ISI-Incontinence Severity Index[15]; MESA-Medical and social Aspects of Aging questionnaire[14]; H&P- History and Physical; PVR- Post void residual volume; MD Dx- Physician diagnosis; Tx Info- Treatment information.